News

American Association for Cancer Research (AACR) 2019 – STRO-001 Poster

April 11, 2019

American Association for Cancer Research (AACR) 2019

A Phase 1 Open-Label, Safety, Pharmacokinetic, And Preliminary Efficacy Study Of STRO-001, An Anti-CD74 Antibody Drug Conjugate, In Patients With Advanced B-Cell Malignancies, NCT03424603